Leading by example: How the Webster team's systematic review quietly rebuked the field's preoccupation with biomarker "disclosure," and why it matters. Lingler JH. J Alzheimers Dis 2026;110:86-88.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lingler JH. Leading by example: How the Webster team's systematic review quietly rebuked the field's preoccupation with biomarker "disclosure," and why it matters. J Alzheimers Dis 2026;110:86-88.
PMID: 41689240